Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Predicting QRS and PR interval prolongations in humans using nonclinical data.

Bergenholm L, Parkinson J, Mettetal J, Evans ND, Chappell MJ, Collins T.

Br J Pharmacol. 2017 Oct;174(19):3268-3283. doi: 10.1111/bph.13940. Epub 2017 Aug 24.

PMID:
28675424
2.

Alterations of Blood Pressure and ECG following Two-Week Consumption of Berberis integerrima Fruit Extract.

Joukar S, Mahdavi N.

Int Sch Res Notices. 2014 Oct 29;2014:209683. doi: 10.1155/2014/209683. eCollection 2014.

3.

Evaluation of Melissa officinalis (Lemon Balm) Effects on Heart Electrical System.

Joukar S, Asadipour H.

Res Cardiovasc Med. 2015 May 23;4(2):e27013. doi: 10.5812/cardiovascmed.4(2)2015.27013. eCollection 2015 May.

4.

Pharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs.

Roden DM.

Card Electrophysiol Clin. 2014 Dec 1;6(4):695-704.

5.

Regulation of intracellular Na(+) in health and disease: pathophysiological mechanisms and implications for treatment.

Coppini R, Ferrantini C, Mazzoni L, Sartiani L, Olivotto I, Poggesi C, Cerbai E, Mugelli A.

Glob Cardiol Sci Pract. 2013 Nov 1;2013(3):222-42. doi: 10.5339/gcsp.2013.30. eCollection 2013. Review.

6.

Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk.

Ritchie MD, Denny JC, Zuvich RL, Crawford DC, Schildcrout JS, Bastarache L, Ramirez AH, Mosley JD, Pulley JM, Basford MA, Bradford Y, Rasmussen LV, Pathak J, Chute CG, Kullo IJ, McCarty CA, Chisholm RL, Kho AN, Carlson CS, Larson EB, Jarvik GP, Sotoodehnia N; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) QRS Group, Manolio TA, Li R, Masys DR, Haines JL, Roden DM.

Circulation. 2013 Apr 2;127(13):1377-85. doi: 10.1161/CIRCULATIONAHA.112.000604. Epub 2013 Mar 5.

7.

Surrogate end points and their role in clinical trial.

Jaykaran.

Indian J Pharmacol. 2009 Feb;41(1):54. doi: 10.4103/0253-7613.48880. No abstract available.

8.

Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects.

Hofmeyr GJ, G├╝lmezoglu AM, Novikova N, Linder V, Ferreira S, Piaggio G.

Bull World Health Organ. 2009 Sep;87(9):666-77. Review.

9.

Antidepressant use, depression, and survival in patients with heart failure.

O'Connor CM, Jiang W, Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR.

Arch Intern Med. 2008 Nov 10;168(20):2232-7. doi: 10.1001/archinte.168.20.2232.

10.

Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart.

Undrovinas A, Maltsev VA.

Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):348-59. Review.

11.

Late sodium current in failing heart: friend or foe?

Maltsev VA, Undrovinas A.

Prog Biophys Mol Biol. 2008 Jan-Apr;96(1-3):421-51. Epub 2007 Aug 10. Review.

12.

Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.

Stokoe KS, Balasubramaniam R, Goddard CA, Colledge WH, Grace AA, Huang CL.

J Physiol. 2007 May 15;581(Pt 1):255-75. Epub 2007 Feb 15.

13.

Chiropractic as spine care: a model for the profession.

Nelson CF, Lawrence DJ, Triano JJ, Bronfort G, Perle SM, Metz RD, Hegetschweiler K, LaBrot T.

Chiropr Osteopat. 2005 Jul 6;13:9.

14.

Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure.

Zicha S, Maltsev VA, Nattel S, Sabbah HN, Undrovinas AI.

J Mol Cell Cardiol. 2004 Jul;37(1):91-100.

15.

Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction.

Rochon PA, Clark JP, Binns MA, Patel V, Gurwitz JH.

CMAJ. 1998 Aug 25;159(4):321-7. Erratum in: CMAJ 1998 Sep 22;159(6):650.

Supplemental Content

Support Center